U.S. Customs and Border Protection (CBP) recently published CSMS #16-000849 to further delay the ACE transition timeline into January 2017.           

At the beginning of September, the mandatory go live date, October 1, was delayed until October 29. With this latest announcement, CBP is now targeting January 2017 as the new mandatory date. This transition includes the mandatory use of ACE for liquidation, drawback, reconciliation, duty deferral, collections, statements, and the Automated Surety Interface.

Today U.S. Customs and Border Protection (CBP) published CSMS# 16-000793 to announce a major change in the ACE transition timeline. The next mandatory go live date, October 1st, is now delayed until October 29th.

The Food & Drug Administration has proposed the following data requirements for the electronic filing of entries of FDA-regulated products in ACE.  The goal of adding these new required elements – many which are optional now – is to expedite automatic release of entries.

The FDA would like feedback on the entire proposal but especially on whether or not any given data element is needed to determine admissibility.